Account
Havas Media wins integrated digital duties of XOLO
MUMBAI: The winning streak continues for Havas Media Group India. The agency has won the integrated digital duties of XOLO, part of Lava International, in a multi-agency pitch.
The size of the digital business is estimated to be upwards of Rs 60 crore.
With a stronghold in the mid to high-end smartphone segment, XOLO’s premium smartphones and tablets with fresh design, new platforms and technologies focus on performance and customer experience.
Havas Media Group, India and South Asia CEO Anita Nayyar said, “We are delighted with the XOLO win close on the back of Yepme.com and a successful last year. It further establishes our digital at core capabilities. Mobile is the future for India and a required essential. We are delighted to work with the team and brand.”
“It is a great win and we are looking at a busy year ahead in terms of new business. We are very happy that XOLO has placed its confidence in our services and our digital specialists,” added Havas Media India MD Mohit Joshi.
XOLO has many first to its credits, that includes tying up with Intel to launch the world’s first Intel processor powered smartphone, the first brand to launch NVIDIA TEGRA 4 powered tablet in India, first regional marketing partner for Liverpool FC club in India and many more.
Havas Media Group India recently won the integrated AOR of Yepme.com.
MUMBAI: BigTrunk Communications, an integrated digital marketing agency known for driving brand transformations across industries, has been awarded the digital marketing mandate for Soframycin, one of India’s most trusted antiseptic cream brands from the EncubeEthicals portfolio. With this collaboration, Soframycin makes its debut into the digital space, aiming to amplify its presence across India through compelling social media narratives and data-led campaigns. BigTrunk will lead the brand’s digital strategy and execution, with a focus on connecting Soframycin’s legacy of trust with today’s health-conscious and digitally engaged audience.
Soframycin has been a household name for generations, widely recognized for its efficacy in treating cuts, burns, and wounds. Backed by the scientific rigor and pharmaceutical expertise of EncubeEthicals, a pharmaceutical powerhouse since 1998, the brand benefits from the expertise of over 1,400 professionals, including more than 200 R&D specialists and a robust team of quality experts. With a presence in over 50 countries, Encube’s commitment to excellence in topical formulations adds deep credibility to Soframycin’s legacy. Now, as the brand enters the digital space, BigTrunk Communications will lead the charge in reimagining Soframycin’s story—creating modern, relatable digital experiences that stay true to its heritage.
“As we take Soframycin into its next chapter of growth, embracing digital media is not just a strategy but a necessity. We wanted a partner who could translate our scientific credibility into engaging, relatable content for today’s audience,” said Soframycin vice president – marketing, Ajay Rawal. “BigTrunk’s deep understanding of healthcare communications and digital behavior makes them the ideal partner to build meaningful narratives around wound care, trust, and wellbeing.”
“Soframycin is more than a product—it’s a legacy deeply rooted in care and science,” added BigTrunk Communications founder & managing director Bharat Subramaniam. “We’re excited to take on this responsibility of guiding a heritage brand into the digital world. Our focus will be on creating contextual storytelling and purpose-driven campaigns that bring Soframycin closer to Indian families, both old and new.”
